TY - JOUR
T1 - Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors
T2 - A Consensus Statement from the EXPERT Working Group
AU - Hansen, Dominique
AU - Niebauer, Josef
AU - Cornelissen, Veronique
AU - Barna, Olga
AU - Neunhaeuserer, Daniel
AU - Stettler, Christoph
AU - Tonoli, Cajsa
AU - Greco, Eugenio
AU - Fagard, Robert
AU - Coninx, Karin
AU - Vanhees, Luc
AU - Piepoli, Massimo F.
AU - Pedretti, Roberto
AU - Ruiz, Gustavo Rovelo
AU - Corra, Ugo
AU - Schmid, Jean-Paul
AU - Davos, Constantinos H.
AU - Edelmann, Frank
AU - Abreu, Ana
AU - Rauch, Bernhard
AU - Ambrosetti, Marco
AU - Braga, Simona Sarzi
AU - Beckers, Paul
AU - Bussotti, Maurizio
AU - Faggiano, Pompilio
AU - Garcia-Porrero, Esteban
AU - Kouidi, Evangelia
AU - Lamotte, Michel
AU - Reibis, Rona
AU - Spruit, Martijn A.
AU - Takken, Tim
AU - Vigorito, Carlo
AU - Voeller, Heinz
AU - Doherty, Patrick
AU - Dendale, Paul
PY - 2018/8
Y1 - 2018/8
N2 - Whereas exercise training is key in the management of patients with cardiovascular disease (CVD) risk (obesity, diabetes, dyslipidaemia, hypertension), clinicians experience difficulties in how to optimally prescribe exercise in patients with different CVD risk factors. Therefore, a consensus statement for state-of-the-art exercise prescription in patients with combinations of CVD risk factors as integrated into a digital training and decision support system (the EXercise Prescription in Everyday practice & Rehabilitative Training (EXPERT) tool) needed to be established. EXPERT working group members systematically reviewed the literature for meta-analyses, systematic reviews and/or clinical studies addressing exercise prescriptions in specific CVD risk factors and formulated exercise recommendations (exercise training intensity, frequency, volume and type, session and programme duration) and exercise safety precautions, for obesity, arterial hypertension, type 1 and 2 diabetes, and dyslipidaemia. The impact of physical fitness, CVD risk altering medications and adverse events during exercise testing was further taken into account to fine-tune this exercise prescription. An algorithm, supported by the interactive EXPERT tool, was developed by Hasselt University based on these data. Specific exercise recommendations were formulated with the aim to decrease adipose tissue mass, improve glycaemic control and blood lipid profile, and lower blood pressure. The impact of medications to improve CVD risk, adverse events during exercise testing and physical fitness was also taken into account. Simulations were made of how the EXPERT tool provides exercise prescriptions according to the variables provided. In this paper, state-of-the-art exercise prescription to patients with combinations of CVD risk factors is formulated, and it is shown how the EXPERT tool may assist clinicians. This contributes to an appropriately tailored exercise regimen for every CVD risk patient.
AB - Whereas exercise training is key in the management of patients with cardiovascular disease (CVD) risk (obesity, diabetes, dyslipidaemia, hypertension), clinicians experience difficulties in how to optimally prescribe exercise in patients with different CVD risk factors. Therefore, a consensus statement for state-of-the-art exercise prescription in patients with combinations of CVD risk factors as integrated into a digital training and decision support system (the EXercise Prescription in Everyday practice & Rehabilitative Training (EXPERT) tool) needed to be established. EXPERT working group members systematically reviewed the literature for meta-analyses, systematic reviews and/or clinical studies addressing exercise prescriptions in specific CVD risk factors and formulated exercise recommendations (exercise training intensity, frequency, volume and type, session and programme duration) and exercise safety precautions, for obesity, arterial hypertension, type 1 and 2 diabetes, and dyslipidaemia. The impact of physical fitness, CVD risk altering medications and adverse events during exercise testing was further taken into account to fine-tune this exercise prescription. An algorithm, supported by the interactive EXPERT tool, was developed by Hasselt University based on these data. Specific exercise recommendations were formulated with the aim to decrease adipose tissue mass, improve glycaemic control and blood lipid profile, and lower blood pressure. The impact of medications to improve CVD risk, adverse events during exercise testing and physical fitness was also taken into account. Simulations were made of how the EXPERT tool provides exercise prescriptions according to the variables provided. In this paper, state-of-the-art exercise prescription to patients with combinations of CVD risk factors is formulated, and it is shown how the EXPERT tool may assist clinicians. This contributes to an appropriately tailored exercise regimen for every CVD risk patient.
KW - RESTING BLOOD-PRESSURE
KW - TYPE-2 DIABETES-MELLITUS
KW - OUTPATIENT CARDIAC REHABILITATION
KW - CONTINUOUS MODERATE EXERCISE
KW - AEROBIC EXERCISE
KW - PHYSICAL-ACTIVITY
KW - GLYCEMIC CONTROL
KW - ENDOTHELIAL FUNCTION
KW - RESISTANCE EXERCISE
KW - INTENSITY EXERCISE
U2 - 10.1007/s40279-018-0930-4
DO - 10.1007/s40279-018-0930-4
M3 - (Systematic) Review article
C2 - 29729003
SN - 0112-1642
VL - 48
SP - 1781
EP - 1797
JO - Sports Medicine
JF - Sports Medicine
IS - 8
ER -